Records containing: Prader-Willi Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-08-03An Open-Label Study of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2021-05-06Transcutaneous Vagus Nerve Stimulation in Children With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2021-02-17A Phase 2b/3 Study to Evaluate the Safety, Tolerability, and Effects of Livoletide (AZP-531), an Unacylated Ghrelin Analogue, on Food-related Behaviors in Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2021-01-29SNP-based Microdeletion and Aneuploidy RegisTry
-
CLINICAL_TRIALS study record update · 2021-01-27Treatment With Growth Hormone in Adults With PWS, Effect on Muscular Tone Evaluated by Functional MRI, Relationship With Strength and Body Composition
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-01-08Assessment of Central Adrenal Insufficiency in Adults With Prader-Willi Syndrome.
-
CLINICAL_TRIALS study record update · 2021-01-08Growth Hormone Use in Adults With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2020-11-12Effects of Intranasal Administrations of Oxytocin on Behavioural Troubles, Hyperphagia and Social Skills in Children With Prader-Willi Syndrome Aged From 3 to 12 Years.
-
CLINICAL_TRIALS study record update · 2020-08-26Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2020-07-07Contribution of a GLP-1 Agonist to Appetite Regulation, Metabolism and Body Composition in Subjects With Prader-Willi Syndrome.
-
CLINICAL_TRIALS study record update · 2020-03-27A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2020-03-05Targeting the Gut Microbiome for Prader-Willi Syndrome Treatment
-
CLINICAL_TRIALS study record update · 2019-06-27A Phase III, Multi-center, Randomized, Comparative, Parallel, Open Study to Assess the Efficacy and Safety After Treatment of Eutropin® Inj. Compared to Genotropin® in Infants/Toddlers With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2019-06-25Intranasal Oxytocin for Treatment of Infants and Children With Prader-Willi Syndrome in Nutritional Phase 1a - Phase 2 Study
-
CLINICAL_TRIALS study record update · 2019-04-26Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation- Induced Modulation of Hyperphagia in Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2019-04-17Proof of Concept Study of Vagus Nerve Stimulation Using an External Device for the Treatment of Behaviour Problems in People With Neurodevelopmental Disorders, Specifically Prader Willi Syndrome
-
CLINICAL_TRIALS study record update · 2019-02-28Therapeutic Effects of Hippotherapy in Children With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2019-01-30Long Term Evaluation of Infants Aged From 3 to 4 Years Old Included in the Ancient Study (Repeated Administrations of Oxytocin in Infants With Prader Willi Syndrome Aged From 0 to 6 Months) and Comparison With Not Treated and Age-matched Prader Willi Syndrome Infants (OT2SUITE)
-
CLINICAL_TRIALS study record update · 2018-06-21Effects of Progressive Elastic Band Resistance Training on Body Composition and Motor Performance in Adults With Prader-Willi Syndrome: a Pilot Study
-
CLINICAL_TRIALS study record update · 2018-06-12A Single Arm, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2018-04-11Randomized, Placebo Controlled Double-blind Study of the Efficacy of Topiramate on the Symptoms of Irritability - Impulsivity, Overeating and Self-harm in a Population of Patients Suffering From Prader Willi Syndrome Over 8 Weeks
-
CLINICAL_TRIALS study record update · 2017-11-06Effects of Transcranial Direct Current Stimulation (tDCS) on Obsessive Compulsive Behavior and Depressive Symptoms on Individuals With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2017-02-24A Trial to Examine the Bioequivalence of Norditropin® Versus Genotropin® in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2017-02-23Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies and Effect on Suck and Food Intake.
-
CLINICAL_TRIALS study record update · 2017-01-26Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months